Evidence map›Paper›PMID 31049853›Full record

ArticleCerebellum (London, England)2019

Cognitive and Psychiatric Evaluation in SYNE1 Ataxia.

Maria Thereza Drumond Gama, Pedro Braga-Neto, Livia Almeida Dutra, Helena Alessi, Lilia Alves Maria, Ary Araripe Gadelha, Bruno Bertolucci Ortiz, Ilda Kunii, Silvia Regina Correia-Silva, Magnus R Dias da Silva and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Maria Thereza Drumond GamaDepartment of Neurology, Ataxia Unit, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Pedro Braga-NetoDivision of Neurology, Department of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, Brazil.ORCID http://orcid.org/0000-0001-9186-9243
Livia Almeida DutraDepartment of Neurology, Ataxia Unit, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Helena AlessiDepartment of Neurology, Ataxia Unit, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Lilia Alves MariaDepartment of Neurology, Ataxia Unit, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Ary Araripe GadelhaDepartment of Psychiatry, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Bruno Bertolucci OrtizDepartment of Psychiatry, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Ilda KuniiDivision of Endocrinology and Metabolism, Laboratory of Molecular & Translational Endocrinology (LEMT), Universidade Federal de São Paulo, Sao Paulo, Brazil.
Silvia Regina Correia-SilvaDivision of Endocrinology and Metabolism, Laboratory of Molecular & Translational Endocrinology (LEMT), Universidade Federal de São Paulo, Sao Paulo, Brazil.
Magnus R Dias da SilvaDivision of Endocrinology and Metabolism, Laboratory of Molecular & Translational Endocrinology (LEMT), Universidade Federal de São Paulo, Sao Paulo, Brazil.
Patrick A DionDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada.
Guy A RouleauDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada.
Marcondes Cavalcante FrançaDepartment of Neurology, State University of Campinas, Campinas, Sao Paulo, Brazil.
Orlando G P BarsottiniDepartment of Neurology, Ataxia Unit, Universidade Federal de São Paulo, Sao Paulo, Brazil. orlandobarsottini@gmail.com.
José Luiz PedrosoDepartment of Neurology, Ataxia Unit, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Universidade Federal de São Paulo · BRMontreal Neurological Institute and Hospital · CAUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Estadual do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SYNE1 gene mutations were identified as a cause of late-onset pure cerebellar syndrome. Non-cerebellar symptoms, including cognitive impairment, were already described in this condition. The aim of this study was to perform a detailed cognitive and psychiatric description of patients with SYNE1 gene mutations. We performed neuropsychological and psychiatric evaluations of six patients with SYNE1 ataxia and compared their performance with 18 normal controls paired for age and education level. SYNE1 ataxia patients present cognitive dysfunction, characterized by impairment in attention and processing speed domains. Otherwise, the psychiatric assessment reported low levels of overall behavioral symptoms with only some minor anxiety-related complaints. Although this is a small sample of patients, these results suggest that SYNE1 ataxia patients may represent a model to investigate effects of cerebellar degeneration in higher hierarchical cognitive functions. For further studies, abstract thinking impairment in schizophrenia may be related to dysfunction in cerebellum pathways.

Indexed as

AdultAge of OnsetAnxietyAttentionCerebellar AtaxiaCognitionCognition DisordersCytoskeletal ProteinsDiagnostic and Statistical Manual of Mental DisordersFemaleHumansMaleMiddle AgedNerve Tissue ProteinsNeuropsychological TestsPsychiatric Status Rating ScalesCytoskeletal ProteinsNerve Tissue ProteinsSYNE1 protein, humanCerebellar cognitive affective syndromeCognitive impairmentHereditary ataxiasSYNE1 mutations

Identifiers

PMID31049853
OpenAlexW2942725194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.